Material characterization and in vivo behavior of silicon substituted α-tricalcium phosphate cement

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 76, Issue 2, 2006, Pages 424-431

  Camiré, Christopher L ^a   Saint Jean, Simon Jegou ^b   Mochales, Carolina ^c   Nevsten, Pernilla ^b   Wang, Jian Sheng ^a   Lidgren, Lars ^a   McCarthy, Ian ^a   Ginebra, Maria Pau ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

Bioactivity; Bone formation; Calcium deficient hydroxyapatite (CDHA); Reactivity; Silicon substituted tricalcium phosphate ( TCP)

Indexed keywords

CALCIUM COMPOUNDS; CELLS; COMPRESSIVE STRENGTH; HYDROLYSIS; SILICON; SYNTHESIS (CHEMICAL);

BIOACTIVITY; BONE FORMATION; CELL DIFFERENTIATION;

BONE CEMENT;

ALPHA TRICALCIUM PHOSPHATE; BONE CEMENT; CALCIUM PHOSPHATE; HYDROXYAPATITE; SILICON; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIMETRY; CELL DIFFERENTIATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; HYDROLYSIS; IMPLANT; IN VIVO STUDY; MESENCHYME; NONHUMAN; OSSIFICATION; OSTEOBLAST; SOLID STATE; STRUCTURE ANALYSIS; SURFACE PROPERTY; SYNTHESIS; TEMPERATURE DEPENDENCE; TENSILE STRENGTH; X RAY DIFFRACTION;

ANIMALS; APATITES; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; CALCIFICATION, PHYSIOLOGIC; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELLS, CULTURED; COMPRESSIVE STRENGTH; MATERIALS TESTING; MESODERM; OSTEOBLASTS; RABBITS; SILICON; STRESS, MECHANICAL; SURFACE PROPERTIES;

EID: 31644450909     PISSN: 00219304     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30385     Document Type: Article

References (41)

1. Albee F, Morrison H. Studies in bone growth. Ann Surg 1920;71:32-38.
2. Brown WE, Chow LC. A new calcium phosphate setting cement. J Dent Res 1983;62:672.
3. Brown WE, Chow LC. A new calcium phosphate water setting cement. In: Brown PW, editor. Cement research progress. American Ceramic Society 1987; 1986. p 351-379.
4. Driessens FCM, Boltong MG, Bermudez O, Planell JA. Formulation and setting times of some calcium orthophosphate cements: a pilot study. J Mater Sci Mater Med 1993;4:503-508.
5. Monoma H, Ueno S, Kanazawa T. Properties of hydroxyapatite prepared by the hydrolysis of tricalcium phosphate. J Chem Technol Biol 1981;31:15-24.
6. Monoma H, Uenso S, Kanazawa T. Composition and properties of hydroxyapatite prepared by the hydration of tricalcium phosphate. Abstr Pap Am Chem Soc 1979; 64.
7. Ginebra MP, Fernández E, Boltong MG, Driessens FCM, Ginebra J, De Maeyer EAP, Verbeeck RMH, Planell JA. Setting reaction and hardening of an apatitic calcium phosphate cement. J Dent Res 1997;76:905-912.
8. Barralet JE, Hofmann M, Grover LM, Gbureck U. High-strength apatitic cement by modification with α-hydroxy acid salts. Adv Mater 2003;15:2091-2095.
9. Takahashi K, Fujishiro Y, Yin S, Sato T. Preparation and compressive strength of α-tricalcium phosphate based cement dispersed with ceramic particles. Ceram Int 2004;30:199-203.
10. Camire CL, Gbureck U, Hirsiger W, Bohner M. Correlating crystallinity and reactivity in an α-tricalcium phosphate. Biomaterials 2005;26:2787-2794.
11. Ginebra MP, Rilliard A, Fernández E, Elvira C, San Román J, Planell JA. Mechanical and rheological improvement of a calcium phosphate cement by the addition of a polymeric drug. J Biomed Mater Res 2001;57:113-118.
12. Leamy P, Brown PW, TenHuisen K, Randall C. Fluoride uptake by hydroxyapatite formed by the hydrolysis of alpha-tricalcium phosphate. J Biomed Mater Res 1998;42:458-464.
13. TenHuisen KS, Brown PW. Hydrolysis of alpha-tricalcium phosphate in NaF solutions. Biomaterials 1999;20:427-434.
14. Bronner F. Principles of bone biology. In: Metals in bone: aluminum, boron, cadmium, chromium, lead, silicon and strontium. Academic Press Inc.; 1996. p 295-303.
15. Hott M, Pollak C, Modrowski D, Marie PJ. Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int 1993;53:174-179.
16. Carlisle EM. Silicon: a possible factor in bone calcification. Science 1970;167:279-280.
17. 1. Calcif Tissue Int 1981;33:27-34.
18. Thompson ID, Hench LL. Mechanical properties of bioactive glasses, glass-ceramics and composites. Proc Inst Mech Eng [H] 1998;212H:127-136.
19. Langstaff S, Sayer M, Smith TJN, Pugh SM. Resorbable bioceramics based on stabilized calcium phosphates. II. Evaluation of biological response. Biomaterials 2001;22:135-150.
20. Phan PV, Grzanna M, Chu J, Polotsky A, El-Ghannam A, Van Heerden D, Hungerford DS, Frondoza CG. The effect of silica-containing calcium-phosphate particles on human osteoblasts in vitro. J Biomed Mater Res. 2003;67A:1001-1008.
21. Gibson IR, King HA, Best SM, Bonfield W. Enhanced in vitro cell activity and surface apatite layer formation on novel silicon-substituted hydroxyapatites. Bioceramics 1999;12:191-194.
22. Patel N, Best SM, Bonfield W, Gibson IR, Hing KA, Damien E, Revell PA. A comparative study on the in vivo behaviour of hydroxyapatie and silicon substituted hydroxyapatite granules. J Mater Sci Mater Med 2002;13:1199-1206.
23. Balas F, Pérez-Pariente J, Vallet-Regí M. In vitro bioactivity of silicon-substituted hydroxyapatites. J Biomed Mater Res 2003;66A:364-375.
24. Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Effect of sintered silicate-substituted hydroxyapatite on remodelling processes at the bone-implant interface. Biomaterials 2004;25:3303-3314.
25. Porter AE, Best SM, Bonfield W. Ultrastructural comparison of hydroxyapatite and silicon-substituted hydroxyapatite for biomedical applications. J Biomed Mater Res 2004;68A:133-141.
26. Porter AE, Botelho CM, Lopes MA, Best SM, Bonfield W. Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo. J Biomed Mater Res 2004;69A:670-679.
27. Song H, Kim SR, Jung SJ, Lee JK, Kim HJ, Kim YH. Dissolution studies of silicon containing self setting bone cement. Key Eng Mat 2005;284-286:169-172.
28. 5. J Am Ceram Soc 1969;52:346-347.
29. Winpow, program for Rietveld refinement, Stahl K., Technical University of Denmark, Lyngby.
30. Hill RJ, Howard CJ. Australian Atomic Energy Commission (now ANSTO), Report M112. New South Wales, Australia: Lucas Heights Research Laboratories; 1986.
31. 2. Acta Crystallogr Sect B 1977;B33:1325-1333.
32. 2. J Solid State Chem 1974;10:232-248.
33. Kay MI, Young RA, Posner AS. Crystal structure of hydroxyapatite. Nature 1964;204:1050-1052.
34. Oyane A, Kim HM, Furuya T, Kokubo T, Miyazaki T, Nakamura T. Preparation and assessment of revised simulated body fluids. J Biomed Mater Res 2003;65A:188-195.
35. Wang JS, Goodman S, Aspenberg P. Bone formation in the presence of phagocytosable hydroxyapatite particles. Clin Othop 1994;304:272-279.
36. Reid JW, Pietak A, Sayer M, Dunfield D, Smith TJN. Phase formation and evolution in the silicon substituted tricalcium phosphate/apatite system. Biomaterials 2005;26:2887-2897.
37. Langstaff S, Sayer M, Smith TJN, Pugh SM, Hesp SAM, Thompson WT. Resorbable bioceramics based on stabilized calcium phosphates. I. Rational design, sample preparation and material characterization. Biomaterials 1999;20:1727-1741.
38. Sayer M, Stratilatov AD, Reid J, Calderin L, Stott MJ, Yin X, MacKenzie M, Smith TJN, Hendry JA, Langstaff SD. Structure and composition of silicon-stabilized tricalcium phosphate. Biomaterials 2003;24:369-382.
39. 2 at 90°C. J Am Ceram Soc 1992;76:1423-1429.
40. Tanizawa Y, Suzuki T. Effects of silicate ions on the formation and transformation of calcium phosphates in neutral aqueous solutions. J Chem Soc Faraday Trans 1995;91:3499-3503.
41. Thian ES, Huang J, Best SM, Barber ZH, Bonfield W. Magnetron co-sputtered silicon-containing hydroxyapatite thin films-an in vitro study. Biomaterials 2005;26:2947-2956.